As for non-alcoholic fatty liver disease (NAFLD) occurring in human beings, metabolic disorder syndromes and obesity are also usually the main causes, with increased plasma insulin and fatty acid concentration, elevated fasting aminotransferase (AST/ALT) and/or triglycerides (TAG) level, and also abnormal lipid accumulation in the liver [19,20,21]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.